AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

NCT00102323 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombocytopenia
Idiopathic Thrombocytopenic Purpura

Interventions

DRUG: Placebo
BIOLOGICAL: AMG 531

Sponsor

Amgen